Search Thermo Fisher Scientific
Search Thermo Fisher Scientific
Working together with laboratories, Thermo Fisher Scientific played a critical role in helping to solve the world’s greatest challenges during the COVID‑19 pandemic. As a leader in the industry, we will continue to be here for you—delivering trusted molecular diagnostic solutions that help you guide effective patient outcomes.
This eBook was designed to educate and inform about the role molecular testing can serve in patient management and its potential impact on global health care decisions. A compilation of informative interviews with key medical experts, this educational content is intended to aid lab professionals and clinicians working in all types of laboratories to better understand and appreciate the potential of molecular testing.
Did you miss our previous eBook on the clinical value of molecular testing? Click here.
Laboratories around the world invested billions in resources to support molecular testing for SARS-CoV-2, but the value of these tests will make a significant impact on global health beyond the pandemic. Molecular testing enables accurate and actionable results that can enhance the quality of patient care and shape the future for healthcare best practices.
While traditional methods continue to have an important role in diagnosis of infectious diseases and other applications, PCR technology has clinical evidence to support improved patient outcomes. The technology is substantial, running thousands of highly sensitive samples with same day results.
Explore the resources below to learn more about the role molecular testing can serve in patient management and care decisions.
Molecular testing has improved diagnosis of circulating respiratory viruses and atypical bacteria.
Learn more ›
Request RTI infographic ›
Discover how to use PCR for the detection of urinary tract infections and the growing evidence for this molecular testing method.
There are challenges in diagnosing infectious gastroenteritis. Molecular testing can enable laboratories to address those challenges.
Learn more ›
Request GI infographic ›
Early and accurate detection and differentiation is the first step toward understanding the cause of infection and determining next steps.
Learn more ›
Request STI infographic ›
Request VM infographic ›
Molecular diagnostic testing for viral hepatitis can be used to confirm hepatitis infection when serology results are unclear, and to monitor viral load levels.
Explore how molecular genomic and genetic testing serve as powerful tools in the global fight to end HIV.
The future of health care includes factoring PGx genetic test results into decision making.
Learn more ›
Request PGx infographic ›
Laboratory spotlights ›
Next step for Molecular Diagnostics and Antimicrobial Resistance: How to Maximize Advanced Technology in the Lab.
Hear from industry leaders as they discuss strategies for designing molecular panels that are both clinically relevant and payor-supported.
CEO of Wise Diagnostic Systems shares insights on practical considerations when shifting from traditional methods to molecular technologies.
A compilation of informative interviews with key medical experts, this is intended to aid lab professionals and clinicians working in all types of laboratories to better understand the clinical value of molecular testing.
This comprehensive review of viral, bacterial, fungal, and parasitic RTIs is divided into four chapters.
This comprehensive HIV learning guide is offered with case studies in four modules and is edited by HIV healthcare experts from Senegal, Nigeria, India, and Brazil.
A white paper about PGx implementation and tools that are readily available.
A three-part educational series hosted in collaboration with Arizona State University.
A white paper comparing clinician-collected or at-home collected samples for testing for STIs.
A white paper showcasing the role of PCR testing.
Molecular testing content for clinical lab professionals and clinicians.
Read blogs